Quick Answer
Apogee Therapeutics, Inc. reported Total Assets of $937.13 million for fiscal year 2025.
Apogee Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $937.13M | +24.3% |
| 2024 | $753.95M | +87.8% |
| 2023 | $401.40M | +164.0% |
| 2022 | $152.06M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $626.16M | -19.3% | -4.8% |
| June 30, 2025 | $657.77M | -17.8% | -7.9% |
| March 31, 2025 | $714.16M | -13.3% | -5.3% |
| December 31, 2024 | $753.95M | +87.8% | -2.9% |
| September 30, 2024 | $776.29M | +82.0% | -3.0% |
| June 30, 2024 | $800.66M | +512.7% | -2.8% |
| March 31, 2024 | $823.66M | — | +105.2% |
| December 31, 2023 | $401.40M | +164.0% | -5.9% |
- Apogee Therapeutics, Inc. showed an increase of +24.3% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Apogee Therapeutics, Inc.’s total assets has grown by 516.3% (from $152.06 million to $937.13 million).
- The most recent figure is from Apogee Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: